{
    "root": "b7562df3-2e18-4454-83e9-e0ebaccf25a9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Glatiramer Acetate",
    "value": "20250207",
    "ingredients": [
        {
            "name": "GLATIRAMER ACETATE",
            "code": "5M691HL4BO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30089"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "glatiramer acetate injection indicated treatment relapsing forms multiple sclerosis ( multiple sclerosis ) , include clinically isolated syndrome , relapsing-remitting disease , active secondary progressive disease , adults .",
        "doid_entities": [
            {
                "text": "multiple sclerosis (DOID:2377)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2377"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "relapsing-remitting disease",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_3408"
            }
        ]
    },
    "contraindications": {
        "text": "\u2022 subcutaneous injection ; doses interchangeable ( 2.1 ) \u2022 glatiramer acetate injection 20 mg/ml per day ( 2.1 ) \u2022 , allow solution warm room temperature ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "glatiramer acetate injection clear , colorless slightly yellow , sterile , nonpyrogenic solution 1 ml single-dose , prefilled syringe fixed \u00bd inch 29 gauge needle supplied : \u202220 mg/ml single-dose , prefilled syringe light blue plunger , individual blister packages supplied 30-count cartons ( ndc 0378-6960-93 ) . glatiramer acetate products administered optional compatible autoinjector . compatible autoinjectors supplied separately available , availability compatible autoinjectors may change time [ ( 5.7 ) patient counseling information ( 17 ) ] . store glatiramer acetate injection refrigerated 2\u00b0 8\u00b0c ( 36\u00b0 46\u00b0f ) . needed , patient may store glatiramer acetate injection room temperature , 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) , one month , refrigeration preferred . avoid exposure higher temperatures intense light . freeze glatiramer acetate injection . glatiramer acetate syringe freezes , discarded . pharmacist : dispense medication guide prescription .",
    "adverseReactions": "glatiramer acetate injection contraindicated patients known hypersensitivity glatiramer acetate mannitol . included anaphylaxis [ ( 5.1 ) ] .",
    "indications_original": "Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.",
    "contraindications_original": "\u2022 For subcutaneous injection only; doses are not interchangeable ( 2.1 ) \u2022 Glatiramer acetate injection 20 mg/mL per day ( 2.1 ) \u2022 Before use, allow the solution to warm to room temperature ( 2.2 )",
    "warningsAndPrecautions_original": "Glatiramer Acetate Injection is a clear, colorless to slightly yellow, sterile, nonpyrogenic solution in a 1 mL single-dose, prefilled syringe with fixed \u00bd inch 29 gauge needle supplied as: \n                  \n                     \n                        \u202220 mg/mL in a single-dose, prefilled syringe with a light blue plunger, in individual blister packages supplied in 30-count cartons (NDC 0378-6960-93). \n                  \n                  Some glatiramer acetate products can be administered by an optional compatible autoinjector. Compatible autoinjectors are supplied separately if available, but the availability of compatible autoinjectors may change with time [see \n                     \n                        Warnings and Precautions (5.7)\n                     \n                      and Patient Counseling Information (17)].\n                  Store glatiramer acetate injection refrigerated at 2\u00b0 to 8\u00b0C (36\u00b0 to 46\u00b0F). If needed, the patient may store glatiramer acetate injection at room temperature, 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F), for up to one month, but refrigeration is preferred. Avoid exposure to higher temperatures or intense light. Do not freeze glatiramer acetate injection. If a glatiramer acetate syringe freezes, it should be discarded.\n                  \n                     PHARMACIST: Dispense a Medication Guide with each prescription.",
    "adverseReactions_original": "Glatiramer acetate injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. Reactions have included anaphylaxis [see Warnings and Precautions (5.1)]\n                     .",
    "drug": [
        {
            "name": "Glatiramer Acetate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30089"
        }
    ]
}